Comparison
Company
Score
Quality
Valuation
Financial
Technical
Why is Lifeline Biotechnologies, Inc. ?
Unrated Stock - No Analysis Available
Quality key factors
Factor
Value
Sales Growth (5y)
-1.27%
EBIT Growth (5y)
-0.76%
EBIT to Interest (avg)
0.08
Debt to EBITDA (avg)
0.27
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
0.21
Tax Ratio
0
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
8.28%
ROE (avg)
8.28%
Valuation Key Factors 
Factor
Value
P/E Ratio
25098
Industry P/E
Price to Book Value
198.06
EV to EBIT
-25098.28
EV to EBITDA
-25098.28
EV to Capital Employed
198.06
EV to Sales
NA
PEG Ratio
418.30
Dividend Yield
NA
ROCE (Latest)
-0.03%
ROE (Latest)
0.20%
Technical key factors
Indicator
Weekly
Monthly
MACD
Bearish
Bearish
RSI
Bullish
Bollinger Bands
Sideways
Sideways
Moving Averages
Mildly Bullish (Daily)
KST
Mildly Bullish
Dow Theory
No Trend
No Trend
OBV
No Trend
No Trend






